Challenges in Biosimilars Pharmacovigilance

This session of the Biosimilars 2018 will look into the future and FDA initiatives that have already been announced to include enhanced tracking and follow-up of post marketing surveillance issues, planned improvements in AERS, and pilots of new post market drug-monitoring strategies and ADR related issues. Biosimilar guidelines for pharmacovigilance practice and pharmacoepidemiology are the points that shall be laid emphasis in this session. U.S. average annual spending growth from 2002 to 2007 was 16% for biologics, compared with 3.7% for drugs. In same proportion pharmacovigilance for biosimilars has been comparatively more than other pharmaceutical products.

  • Current problems in biosimilars pharmacovigilance
  • Adverse drug reactions with biologics and biosimilar products
  • Detection and evaluation of drug safety signals
  • Role of pharma industries in the improvement of pharmacovigilance system
  • Good pharmacovigilance practice and pharmacoepidemiology

Related Conference of Challenges in Biosimilars Pharmacovigilance

September 24-25, 2020

20th World Congress on Advances in Pharmaceutical Sciences

Singapore, Singapore
October 05-06, 2020

International Congress on Drug Delivery

Auckland, Newzealand
October 15-16, 2020

nanomedicine-pharma-2020

Rome, Italy
October 21-22, 2020

20th Annual Meet on Pharmaceutical Sciences

Bangkok, Thailand
October 21-22, 2020

27th World Congress on Pharmacovigilance and Clinical Trials

Frankfurt, Germany
October 26-27, 2020

22nd International Conference on Drug Design and Development

Amsterdam, Netherlands
November 09-10, 2020

2nd World Congress on Drug Discovery and Drug Design

Tokyo, Japan
November 09-10, 2020

21st Global Summit on Analytical and Bioanlaytical Techniques

Amsterdam, Netherlands
November 9-10, 2020

Annual Meet on Pharmacovigilance & Drug Safety

Tokyo, Japan
November 09-10, 2020

20th Medicinal & Pharmaceutical Sciences Congress

Budapest, Hungary
November 09-10 , 2020

Asia Pacific Pharmaceutics & Drug Delivery Congress

| Tokyo , Japan
November 11-12, 2020

4th World Congress on Eye and Vision

Dubai, UAE
November 16-17, 2020

World Congress on Biologics and Biosimilars

Kyoto, Japan
November 19-20, 2020

Global summit on Cosmetic and Reconstructive Surgery

Tokyo, Japan
November 23-24, 2020

Pharma Expo China

Paris, France
November 23-24, 2020

Pharmaceutics & Novel Drug Delivery Summit China

Paris, France
November 23-24, 2020

21st Middle East PharmaTech & Expo

Istanbul, Turkey
November 25-26, 2020

8th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance

Singapore City, Singapore
November 26-27, 2020

11th World Congress on Bioavailability and Bioequivalence

Istanbul, Turkey
December 02-03, 2020

2nd International Conference on Bio-Pharmaceuticals

Auckland, Newzealand
December 07-08, 2020

International Liver Congress

Dubai, UAE
December 07-08, 2020

International Conference on Biotechnology and Healthcare

Auckland, Newzealand
January 22-23, 2021

1 st Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
January 22-23, 2021

1 st World Congress on Rare Diseases & Orphan Drugs

Prague, Czech Republic
February 26-27, 2021

2nd Annual Congress on Antibiotics and Bacterial Infections

Geneva, Switzerland
March 10-11, 2021

6th Pharmaceutical Chemistry Conference

Paris, France
May 17-18, 2021

8th European Biopharma Congress

Prague, Czech Republic
May 19-20, 2021

36th World Pharmacology and Therapeutics Forum

Singapore, Singapore
June 07-08, 2021

2rd European Conference on Pharmacovigilance and Drug Safety

Prague, Czech Republic

Challenges in Biosimilars Pharmacovigilance Conference Speakers

Recommended Sessions

Related Journals

Are you interested in